TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

XACIATO

CLINDAMYCIN PHOSPHATE
Infectious Disease Approved 2021-12-07
1
Indication
--
Phase 3 Trials
1
Priority Reviews
4
Years on Market

Details

Status
Prescription
First Approved
2021-12-07
Routes
VAGINAL
Dosage Forms
GEL

Companies

Active Ingredient: CLINDAMYCIN PHOSPHATE

XACIATO Approval History

Loading approval history...

What XACIATO Treats

1 indications

XACIATO is approved for 1 conditions since its original approval in 2021. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Bacterial Vaginosis
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

XACIATO FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

XACIATO is a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older. 1.1 Bacterial Vaginosis XACIATO ยฎ is indicated for the treatment of bacterial vaginosis in females 12 years and older [see Use in Specific Populations and Clinical Studies ] .

XACIATO Patents & Exclusivity

Latest Patent: Sep 2036
Exclusivity: Dec 2029

Patents (2 active)

US11129896 Expires Sep 22, 2036
US12303563 Expires Sep 22, 2036

Exclusivity

NP Until Dec 2024
GAIN Until Dec 2029
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.